ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,533,393, issued on Jan. 27, was assigned to Linnane Pharma AB (Malmo, Sweden).
"Vibrio cholerae protein for use against cancer" was invented by Sun Nyunt Wai (Umea, Sweden), Bernt Eric Uhlin (Umea, Sweden), Aftab Nadeem (Malmo, Sweden) and Karina Persson (Umea, Sweden).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to a Vibrio cholerae MakA (motility associated killing factor A) protein for use in therapy, in particular in the treatment or alleviation of cancer such as colorectal cancer. The invention further relates to pharmaceutical compositions comprising a Vibrio cholerae MakA protein as an active ingredient, as well as to metho...